Leveraging alcohol use disorder screening for treatment in routine perioperative care: alluscare
Active Grant Awarded Last action
- Award ID
- R34AA031020
- Recipient
-
Regents Of The University Of Michigan UEI GNJ7BBP73WE9 Part of Board Of Regents Of University Of Nebraska
- Awarding agency
-
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health, Department of Health and Human Services
- Obligated
- $759,141
Award facts
- Assistance listing
- 93.273 Alcohol Research Programs
- Completion date 74% complete
- Place of performance
- Ann Arbor, MI 48108, USA
Award details come from USAspending.gov.
Description
- Abstract
- Alcohol consumption adversely affects up to 28% of hospitalized patients and contributes to a loss of 133 million disability-adjusted life years and 5.3% of worldwide deaths each year. As alcohol use has substantial health and economic impact, much attention has been directed toward the numerous adverse health outcomes in patients with unhealthy alcohol use. Alcohol use disorder (AUD) occurs on a spectrum from mild to severe and is precipitated by binge drinking and heavy alcohol use. We and others have shown that AUD is a modifiable perioperative risk factor and is present in up to 18% of surgical patients. Despite its significant clinical impact, AUD is often overlooked in the design of perioperative care plans. Although AUD affects 9% of the US population, less than one in ten individuals with AUD receives any treatment. Barriers to treatment are multiple and include scarce care availability, limited access, and social stigma. Although anesthesiologists routinely provide guideline- concordant treatment for non-operative medical conditions such as coronary artery disease, AUD-specific care is rarely provided, even to high-risk patients. Thus, there is a compelling opportunity to integrate AUD screening and treatment into routine perioperative care. Our central hypotheses are that AUD health services initiated in the perioperative period will 1) leverage the significant resources made available to perioperative care in the US, 2) forge novel synergistic alliances between previously disconnected healthcare settings, and 3) break down barriers to access to care for health disparity populations. A multi-institutional team of anesthesiologists, biostatisticians, psychologists, and psychiatrists with expertise in AUD treatment and novel clinical trial designs will lead the leveraging alcohol use disorder screening for treatment in routine perioperative care: alluscare proposal and proposes three aims: 1) leverage our existing EHR-integrated alcohol use disorders identification test-concise (AUDIT-C) screening tool to increase provision of AUD-specific perioperative care, 2) conduct a two-center prospective observational cohort study to assess patient acceptability of interventions, feasibility of outcome data collection, and optimum outcome measures for a future pragmatic trial, and 3) optimize perioperative AUD intervention bundles most likely to be effective in a future pragmatic randomized factorial cluster trial through a health equity lens. This R34 planning grant will lay the groundwork for identifying the most effective health service intervention bundles in surgical patients at high risk for AUD. To maximize inclusion of NIH health disparity populations, we will conduct our study in two centers that serve inner-city and rural populations and will deliberately include patients aged 12 years and older. At the conclusion of alluscare, we will have established the research team, designed an AUD intervention bundle most likely to be effective in a future multi-center pragmatic trial, demonstrated a single-IRB governed uniform data collection and entry process, and confirmed the acceptability and feasibility of the future pragmatic trial.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $161,761 | |
| Amendment | $0 | |
| Amendment | $266,550 | |
| Amendment | -$266,549 | |
| Amendment | $266,550 | |
| Original award | $330,829 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Regents Of The University Of Michigan | $56,084 | |
| University Of Texas Health Science Center At Houston | $162,786 | |
| Sporedata Inc. | $42,000 |
Quick answers
Who received award R34AA031020?
R34AA031020 was awarded to Regents Of The University Of Michigan by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on September 19, 2024.
How much is award R34AA031020 worth?
$759,141 has been obligated on R34AA031020.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award